Literature DB >> 30252934

Primary sclerosing cholangitis leads to dysfunction and loss of MAIT cells.

Erik von Seth1,2, Christine L Zimmer3, Marcus Reuterwall-Hansson4,5, Ammar Barakat1,2, Urban Arnelo4,5, Annika Bergquist1,2, Martin A Ivarsson3, Niklas K Björkström3.   

Abstract

Primary sclerosing cholangitis (PSC) is a severe chronic liver disease of the small and large bile ducts. The pathogenesis is unknown but a strong immune cell component has been suggested. Mucosal-associated invariant T (MAIT) cells are abundant in human liver and localize around bile ducts. Yet, the role of MAIT cells in PSC remains unclear. Here, we performed a detailed characterization of MAIT cells in circulation and assessed their presence in bile ducts of PSC patients as well as non-PSC controls. We observed a dramatic reduction in MAIT cell levels in PSC patients. High-dimensional phenotypical analysis using stochastic neighbor embedding revealed the MAIT cells to be activated, a phenotype shared by the investigated disease control groups. In line with the noted phenotypic alterations, MAIT cell function was reduced in response to Escherichia coli and to cytokine stimulation in PSC patients as compared to healthy controls. Using a novel sampling approach of human bile ducts, we found MAIT cells to be specifically enriched within bile ducts. Finally, distinct from the dramatic decline observed in circulation, PSC-patients had retained levels of MAIT cells within bile ducts. Altogether, our results provide a detailed insight into how the human MAIT cell compartment is affected in PSC.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Gut-liver axis; Inflammation; Inflammatory bowel disease; Mucosal-associated invariant T cells; Primary sclerosing cholangitis

Mesh:

Substances:

Year:  2018        PMID: 30252934     DOI: 10.1002/eji.201847608

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

Review 1.  MAIT cells in liver inflammation and fibrosis.

Authors:  Hema Mehta; Martin Joseph Lett; Paul Klenerman; Magdalena Filipowicz Sinnreich
Journal:  Semin Immunopathol       Date:  2022-05-31       Impact factor: 11.759

Review 2.  Mucosal-Associated Invariant T cell in liver diseases.

Authors:  Yujue Zhang; Derun Kong; Hua Wang
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 6.580

Review 3.  Intestinal homeostasis in autoimmune liver diseases.

Authors:  Qiaoyan Liu; Wei He; Ruqi Tang; Xiong Ma
Journal:  Chin Med J (Engl)       Date:  2022-07-20       Impact factor: 6.133

4.  Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis.

Authors:  Martin Kummen; Louise B Thingholm; Malte C Rühlemann; Kristian Holm; Simen H Hansen; Lucas Moitinho-Silva; Timur Liwinski; Roman Zenouzi; Christopher Storm-Larsen; Øyvind Midttun; Adrian McCann; Per M Ueland; Marte L Høivik; Mette Vesterhus; Marius Trøseid; Matthias Laudes; Wolfgang Lieb; Tom H Karlsen; Corinna Bang; Christoph Schramm; Andre Franke; Johannes R Hov
Journal:  Gastroenterology       Date:  2020-12-31       Impact factor: 22.682

Review 5.  Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.